NCT01131949View on ClinicalTrials.gov

Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 28, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Lamotrigine

Lamotrigine Tablets (chewable, dispersible), 25 mg

Trial Locations (1)

27514

AAI Clinic, Chapel Hill

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY